HERSTELLUNGSMETHODE FÜR EINE LEVOTHYROXINLÖSUNG
European patent · EP2683361 · In force
Register entry
- Publication number
- EP2683361
- Application number
- EP11711688
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Maintained in amended form
- Filed
- Mar 10, 2011
- Published
- Jan 15, 2014
- Granted
- Nov 25, 2015
- Protection ends at the latest
- Mar 9, 2031
- Next annual fee due
- Mar 31, 2027
- IPC classes
- A61K 9/08 (2006.01)A61K 31/055 (2006.01)
- PCT application
- PCT/IB2011/051015 10.03.2011
- PCT publication
- WO2012/120338 13.09.2012
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 20, 2026
Agent’s address changed
- Representative
- Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich
Published in Swissreg on 20.10.2026
- Apr 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.03.2026 → 31.03.2027
Published in Swissreg on 01.04.2026
- Apr 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.03.2025 → 31.03.2026
Published in Swissreg on 01.04.2025
- Apr 1, 2024
Change
Published in Swissreg on 01.04.2024
- Nov 8, 2023
Change
Published in Swissreg on 08.11.2023
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- Jul 30, 2021
Address changed
- Owner
- EMP Pharma GmbH, Bodmerstrasse 7, 8002 Zürich → HELM Swiss GmbH, Bodmerstrasse 7, 8002 Zürich
Published in Swissreg on 30.07.2021
- Jan 13, 2016
Agent entered
- Representative
- Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich
Published in Swissreg on 13.01.2016
1 earlier entry
- Nov 25, 2015
Granted
Published in Swissreg on 25.11.2015
Parties
Inventor
GR-19500 Lavrion, Attica, GR
GR-19500 Lavrion, Attica, GR
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.